| Hans-Günter Meyer-Thompson | International
Strengthening the role of the World Health Organization in global drug policy
Strengthening the role of the World Health Organization in global drug policy
Health should be at the centre of the global drug policy debate. After all, the primary reason for the creation of the UN drug control regime is the protection of the ‘health and welfare of mankind’, as the preambles of the 1961, 1971 and 1988 UN drug conventions put it. As the lead entity on health matters within the UN system, the World Health Organization (WHO) is uniquely placed to fulfil a broad mandate in articulating a more progressive approach that truly puts people’s health, wellbeing and human rights at the centre of drug policies. (idpc - International Drug Policy Consortium, UK, 19.06.2019)